Founded in January 2011, Spring Pharma is a high-tech enterprise that mainly engages in researching, manufacturing and marketing of APIs and pharmaceutical intermediates. Spring pharma is located in Jiangsu life science & technology innovation park, with a convenient transportation and excellent infrastructure.
As an innovative enterprise, Spring Pharma has established a enterprise R & D center which occupies 16000 spuare-feet. Its R & D scope diversified range, namely chemical synthesis, analytical chemistry service and formulation development. Over the past three years, we have successfully developed series products of oncology, cardiovascular, anti-infective, antiepileptic and we also set up a heterocyclic fragment library containing more than 2000 pharmaceutical intermediates.
Spring Pharma has an active, experienced, competitive team which had a team of 4 initially to 20 chemists though 3 years, especially, the management team is consisted of senior experts who have more than 30 years experience in the field of pharmaceutical research, development, production and management. In addition, we have established closely cooperative relationships with several research institutes through founding co-laboratory with them, collaborating to develop and research new drugs.
The R&D department is comprised of synthesis, high-pressure hydrogenation, pilot and pharmaceutical preparation laboratory. The quality inspection center equips with specialized analytical instruments and highly trained QC staff. Based on advanced technology, strict quality control system, we are always providing products in excellent quality.
With the business philosophy of “Quality first, Credit most”, we will make efforts to bring value to the healthcare of human being and create a bright future together with our partners!
